Genprex Signs Exclusive License to Additional Diabetes Technology with the University of Pittsburgh
- Thursday, January 5, 2023, 7:04
- Finance
- Add a comment
Technologies Licensed from University of Pittsburgh May Have the Potential to Provide Long-Term Efficacy and to Change the Course of this Disease for the Millions of Patients Around the World with Type 1 or Type 2 Diabetes AUSTIN, Texas, Jan. 5, 2023 /PRNewswire/ — Genprex, Inc….
About the Author
adminasapcorp has written 41546 stories on this site.